OUD in Pregnancy Initiative
NeoQIC and MPQC have been working on NAS and opioid use in pregnancy for some time, and we formally joined together in this work last year as PNQIN. Thus far, most of our attention has focused on the care of the substance-exposed newborn and the family after birth. Based on great work that has already been done at several centers, we’d like to now dig deeper into collaborative efforts focused on the mother and the care of OUD in pregnancy. We’re planning a similar model to what MPQC and NeoQIC have used in the past: hospital and outpatient improvement teams and improvement projects, data sharing, a webinar QI training series, and poster presentations at our PNQIN statewide summits. We are collecting a couple maternal-focused metrics, including one of our primary outcomes of percent of mothers receiving MAT during pregnancy, and we hope to add additional obstetric-focused measures over time. There are a number of infant based measures as well, extending into the year after delivery. To view information about our project on Substance Exposed Newborns, click here.
In February we held a kick-off meeting to bring teams together and start to share ideas and where we all are in our care process for OUD in pregnancy. The slides for this meeting are available here. See the menu below for more project information.
If you would like more information about this initiative, please email Mary Houghton at email@example.com